Loading...
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial.
Iveson, T Kerr, R Saunders, Mark P Cassidy, J Hollander, N Tabernero, J Haydon, A Glimelius, B Harkin, A Allan, K
Iveson, T
Kerr, R
Saunders, Mark P
Cassidy, J
Hollander, N
Tabernero, J
Haydon, A
Glimelius, B
Harkin, A
Allan, K
Citations
Altmetric:
Abstract
6 months of oxaliplatin-containing chemotherapy is usually given as adjuvant treatment for stage 3 colorectal cancer. We investigated whether 3 months of oxaliplatin-containing chemotherapy would be non-inferior to the usual 6 months of treatment.
Authors
Iveson, T
Kerr, R
Saunders, Mark P
Cassidy, J
Hollander, N
Tabernero, J
Haydon, A
Glimelius, B
Harkin, A
Allan, K
McQueen, J
Scudder, C
Boyd, K
Briggs, A
Waterston, A
Medley, L
Wilson, C
Ellis, R
Essapen, S
Dhadda, A
Harrison, M
Falk, S
Raouf, S
Rees, C
Olesen, R
Propper, D
Bridgewater, J
Azzabi, A
Farrugia, D
Webb, A
Cunningham, D
Hickish, T
Weaver, A
Gollins, S
Wasan, H
Paul, J
Kerr, R
Saunders, Mark P
Cassidy, J
Hollander, N
Tabernero, J
Haydon, A
Glimelius, B
Harkin, A
Allan, K
McQueen, J
Scudder, C
Boyd, K
Briggs, A
Waterston, A
Medley, L
Wilson, C
Ellis, R
Essapen, S
Dhadda, A
Harrison, M
Falk, S
Raouf, S
Rees, C
Olesen, R
Propper, D
Bridgewater, J
Azzabi, A
Farrugia, D
Webb, A
Cunningham, D
Hickish, T
Weaver, A
Gollins, S
Wasan, H
Paul, J
Description
Date
2018-04
Publisher
Collections
Keywords
Type
Article
Citation
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial. 2018, 19(4): 562-578 Lancet Oncol